Influence of age on rat bone-marrow mesenchymal stem cells potential

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Fafian Labora J ^a   Fernandez Pernas P ^a   Fuentes, I ^a   De Toro, J ^a   Oreiro, N ^b   Sangiao Alvarellos, S ^c   Mateos, J ^a   Arufe, M C ^a  

^a INIBIC   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

^c CHUAC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TARGET OF RAPAMYCIN KINASE;

AGING; ANIMAL; BONE MARROW CELL; CELL PROLIFERATION; CYTOLOGY; ISOTOPE LABELING; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SIGNAL TRANSDUCTION; WISTAR RAT;

AGING; ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; ISOTOPE LABELING; MALE; MESENCHYMAL STROMAL CELLS; PLURIPOTENT STEM CELLS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84947593535     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16765     Document Type: Article

References (46)

1. Murphy, M. B., Moncivais, K., Caplan, A. I. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Experimental & Molecular Medicine. 45, e54 (2013).
2. Bach, M., Schimmelpfennig, C., Stolzing, A. Influence of murine mesenchymal stem cells on proliferation, phenotype, vitality, and cytotoxicity of murine cytokine-induced killer cells in coculture. PLoS One. 9, e88115 (2014).
3. Zhang, L. et al. The Effects of Mesenchymal Stem Cells in Craniofacial Tissue Engineering. Current Stem Cell Research & Therapy. 9, 280-289 (2014).
4. Yeh, H. Y. et al. Neocartilage formation from mesenchymal stem cells grown in type II collagen-hyaluronan composite scaffolds. Differentiation. 86, 171-183 (2014).
5. Song, J. Q. et al. Effect of treadmill exercise timing on repair of full-thickness defects of articular cartilage by bone-derived mesenchymal stem cells: an experimental investigation in rats. PLoS One. 9, e90858 (2014).
6. Jin, H. J. et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. International Journal of Molecular Sciences. 14, 17986-18001 (2013).
7. Gharibi, B. et al. Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells. Stem Cells. 32, 2256-2266 (2014).
8. Tawonsawatruk, T. et al. Growth kinetics of rat mesenchymal stem cells from 3 potential sources: bone marrow, periosteum and adipose tissue. Journal of the Medical Association of Thailand. 95, 189-197 (2012).
9. Geißler, S. et al. Functional comparison of chronological and in vitro aging: differential role of the cytoskeleton and mitochondria in mesenchymal stromal cells. PLoS One. 7, e52700 (2012).
10. Mantovani, C. et al. Morphological, molecular and functional differences of adult bone marrow-and adipose-derived stem cells isolated from rats of different ages. Experimental Cell Research. 318, 2034-2048 (2012).
11. Tsai, C. C. et al. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood. 117, 459-469 (2011).
12. Han, J. et al. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells. 30, 2746-2759 (2012).
13. Hay, N., Sonenberg, N. Upstream and downstream of mTOR. Genes & Devolopment. 18, 1926-1945 (2004).
14. Anisimov, V. N. et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle. 10, 4230-4236 (2011).
15. Menendez, J. A. et al. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell Cycle. 10, 3658-3677 (2011).
16. Mearadji, A. et al. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Anticancer Drugs. 19, 607-612 (2008).
17. Zhang, N. et al. Biodegradable polymeric micelles encapsulated JK184 suppress tumor growth through inhibiting Hedgehog signaling pathway. Nanoscale. 7, 2609-2624 (2015).
18. Karaoz, E. et al. Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers. Histochemistry and Cell Biology. 132, 533-546 (2009).
19. Livak, K. J., Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods. 25, 402-408 (2001).
20. Matsushime, H. et al. D-type cyclin-dependent kinase activity in mammalian cells. Molecular and Cellular Biology. 14, 2066-2076 (1994).
21. Szklarczyk, D. et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Research. 39, 561-568 (2011).
22. Harting M., Jimenez F., Pati S. et al. Immunophenotype characterization of rat mesenchymal stromal cells. Cytotherapy. 10, 243-253 (2008).
23. Mateos, J. et al. Proteomic applications in the study of human mesenchymal stem cells. Proteomes. 2, 53-71 (2008).
24. Jadaliha, M. et al. Quantitative proteomic analysis of human embryonic stem cell differentiation by 8-plex iTRAQ labelling. PLoS One. 7, e38532 (2012).
25. Scholzen, T., Gerdes, J. The Ki-67 protein: from the known and the unknown. The Journal of Cellular Physiology. 182, 311-322 (2000).
26. Blazquez-Martinez, A. et al. C-Kit identifies a subpopulation of mesenchymal stem cells in adipose tissue with higher telomerase expression and differentiation potential. Differentiation. 3, 147-160 (2014).
27. Das, S. et al. "Over-expression of 60s ribosomal L23a is associated with cellular proliferation in SAG resistant clinical isolates of Leishmania donovani. PLoS Neglected Tropical Diseases. 7, e2527 (2013).
28. Toma-Jonik, A. et al. Active heat shock transcription factor 1 supports migration of the melanoma cells via vinculin downregulation. Cellular Signaling. 27, 394-401 (2015).
29. Piltti, J. et al. Rho-kinase inhibitor Y-27632 increases cellular proliferation and migration in human foreskin fibroblast cells. Proteomics. 15, 2953-2965 (2015).
30. Holle, A. W. et al. In situ Mechanotransduction via Vinculin regulates stem cell differentiation. Stem Cells. 31, 10.1002/stem.1490. (2013).
31. Bujalska, I. J. et al. A swith in dehydrogenase to reductase activity of 11-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. Mech Ageing Dev. 124, 747-757 (2013).
32. Yoon, Y. S. et al. Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. Journal of Cellular Physiology. 209, 468-480 (2006).
33. Wu, J. et al. TGF-1 induces senescence of bone marrow mesenchymal stem cells via increase of mitochondrial ROS production. BMC Developmental Biology. 14, 10.1186/1471-213X-14-21 (2014).
34. Terme, J. M. et al. Histone H1 variants are differentially expressed and incorporated into chromatin during differentiation and reprogramming to pluripotency. The Journal of Biological Chemistry. 286, 35347-35357 (2011).
35. Horne, G. A. et al. Nanog Requires BRD4 to Maintain Murine Embryonic Stem Cell Pluripotency and Is Suppressed by Bromodomain Inhibitor JQ1 Together with Lefty1. Stem Cells Development. 24, 879-891 (2015).
36. Bermeo, S. et al. Lamin A/C Acts as an Essential Factor in Mesenchymal Stem Cell Differentiation through the Regulation of the Dynamics of the Wnt/-Catenin Pathway. Journal Cell Biochemistry. 4, 10.1002/jcb.25185. (2015).
37. Mateos J., Dela Fuente A., Lesende-Rodriguez I. et al. Lamin A deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress. Stem Cell Res. 11, 1137-1148 (2013).
38. Stolzing, A., Scutt, A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell. 5, 213-224 (2006).
39. Easley, C. A. et al. mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells. Cell Reprogramming. 12, 263-273 (2010).
40. Lin, R. et al. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Molecular Cell. 51, 506-518 (2013).
41. Pttappa, G. et al. The metabolism of human stem cells during proliferation and differentiation. J Cell Physiol. 226, 2562-2570 (2011).
42. Sabers, C. J. et al. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. The Journal of Biological Chemistry. 270, 815-822 (1995).
43. Martins I., Galluzzi L., Kroemer G. Hormesis cell death and aging. Aging. 3, 821-828 (2011).
44. Luo, Y. et al. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence. Transplantation. 97, 20-29 (2014).
45. Dillenburg, C. S., Martins, M. D., Meurer, L., Castilho, R. M., Squarize, C. H. Keratoacanthoma of the Lip: Activation of the mTOR Pathway, Tumor Suppressor Proteins, and Tumor Senescence. Medicine. 94, e1552 (2015).
46. Yang, A. et al. Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition. Stem Cells Int. 561404, 10.1155/2015/561404. (2015).